Real-time enrollment status for this human immunodeficiency virus type 1 (hiv-1) infection clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:26 PM UTC
| NCT Number | NCT07266831 |
| Recruiting Status | Recruiting |
| Condition | Human Immunodeficiency Virus Type 1 (HIV-1) Infection |
| Phase | PHASE2 |
| Target Enrollment | 570 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | September 21, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT07266831 is currently recruiting participants. This phase2 study for human immunodeficiency virus type 1 (hiv-1) infection is actively seeking new participants at 24 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07266831 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07266831 was last updated 3 weeks ago (September 21, 2026). HelloStudys verifies this status automatically.